Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc. (FOLD)

$9.8

Amicus Therapeutics, Inc. (FOLD) Share Price Forecast
Currently 17 wall-street analysts regularly analyze the financials of Amicus Therapeutics, Inc. on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Amicus Therapeutics, Inc. (FOLD) have a share price target of $17.33. This median of share price forecast represents a 76.84% upside from the latest price of $9.8 as on 02.06.24.

Amicus Therapeutics, Inc. (FOLD) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Amicus Therapeutics, Inc. (FOLD) share price will touch around $17.33 in next 12-months.
Amicus Therapeutics, Inc. (FOLD) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Amicus Therapeutics, Inc.'s share price and its median forecast price. As on 02.06.24, the difference is -39.82%

Amicus Therapeutics, Inc. (FOLD): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Amicus Therapeutics, Inc. (FOLD) Share Price : Analyst Recommendation
Based on 17 analysts tracking and researching Amicus Therapeutics, Inc. (FOLD) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
8
8
8
Outperform
5
5
5
Hold
4
4
4
Underperform
0
0
0
Sell
0
0
0
Amicus Therapeutics, Inc. (FOLD) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Amicus Therapeutics, Inc. (FOLD) is $17.33, offered by 17 analysts offering 12-month price forecasts.

Amicus Therapeutics, Inc. (FOLD) has a maximum of 0.77 upside potential, based on 17 analysts offering 12-month price forecasts.

Based on 17 analysts tracking and researching Amicus Therapeutics, Inc. (FOLD), 76.47% have a buy recommendation. Remaining 23.53% have either sell or hold recommendations.

The latest share price of Amicus Therapeutics, Inc. (FOLD) is $9.8 as of 02/06/2024.

13 of total 17 analysts offering stock ratings for Amicus Therapeutics, Inc. FOLD have recommended buy rating.